The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 29 March 2004 doi:10.1084/jem.20031272
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 7, 1011-1016
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 152K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goriely, S.
Right arrow Articles by Goldman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goriely, S.
Right arrow Articles by Goldman, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Brief Definitive Report

A Defect in Nucleosome Remodeling Prevents IL-12(p35) Gene Transcription in Neonatal Dendritic Cells

Stanislas Goriely1, Carine Van Lint2, Réza Dadkhah1, Myriam Libin1, Dominique De Wit1, Dominique Demonté2, Fabienne Willems1, and Michel Goldman1

1 Laboratoire d'Immunologie Expérimentale, Université Libre de Bruxelles, B-1070 Bruxelles et Institut d'Immunologie Médicale, B-6041 Gosselies, Belgium
2 Service de Chimie Biologique, Laboratoire de Virologie Moléculaire, Institut de Biologie et Médecine Molécularies, Université Libre de Bruxelles, B-6041 Gosselies, Belgium

Address correspondence to Michel Goldman, Hôpital Erasme, Dept. of Immunology, 808 route de Lennik, B-1070 Brussels, Belgium. Phone: 32-2-555-38-62; Fax: 32-2-555-44-99; email: mgoldman{at}ulb.ac.be

To gain insight into the inability of newborns to mount efficient Th1 responses, we analyzed the molecular basis of defective IL-12(p35) expression in human neonatal monocyte-derived dendritic cells (DCs). Determination of IL-12(p35) pre-mRNA levels by real-time RT-PCR revealed that transcriptional activation of the gene in lipopolysaccharide-stimulated neonatal DCs was strongly impaired compared with adult DCs. We next showed that p50/p65 and p65/p65 dimers interact with kB#1 site, a critical cis-acting element of the IL-12(p35) promoter. We found that LPS-induced p65 activation was similar in adult and newborn DCs. Likewise, in vitro binding activity to the Sp1#1 site, previously shown to be critical for IL-12(p35) gene activation, did not differ in adults and newborns. Since the accessibility to this Sp1#1 site was found to depend on nucleosome remodeling, we used a chromatin accessibility assay to compare remodeling of the relevant nucleosome (nuc-2) in adult and neonatal DCs. We observed that nuc-2 remodeling in neonatal DCs was profoundly impaired in response to lipopolysaccharide. Both nuc-2 remodeling and IL-12(p35) gene transcription were restored upon addition of recombinant interferon-{gamma}. We conclude that IL-12(p35) transcriptional repression in neonatal DCs takes place at the chromatin level.

Key Words: cord blood • newborn • nucleosome • NF-{kappa}B • Sp1


The online version of this article contains supplemental material.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS